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O B J E C T I V E S The purpose of this study was to determine the role of adenosine stress cardiac
magnetic resonance (CMR) for risk stratiﬁcation in patients with coronary artery stenoses of intermediate
angiographic severity.
B A C KG ROUND Coronary angiography only provides a morphological description of coronary
lesions. As the patient’s prognosis is closely related to the functional signiﬁcance of angiographically
detected coronary lesions, a functional assessment is desirable in patients with coronary artery stenoses
of intermediate severity.
METHOD S Myocardial perfusion measurements at rest and adenosine stress were performed on 81
patients (75.6% male, mean age 64.2 years) with stable angina pectoris (AP) and coronary artery stenoses
of intermediate angiographic severity (50% to 75%). Regardless of the CMR result, all patients were
treated conservatively with an intensiﬁed medical treatment, and a follow-up was performed after 18 
8 months and 30  8 months. The primary end point was deﬁned as a major adverse cardiac event
(MACE): all-cause death, stroke, acute coronary syndrome; the secondary end point was deﬁned as target
vessel revascularization. Furthermore, AP and dyspnea were evaluated.
R E S U L T S After the follow-up period of 30  8 months, 9 patients with perfusion deﬁcit (PD) suffered
fromMACE, whereas no MACE occurred among the 36 patients without PD (p 0.014). Among patients who
had MACE, the number of ischemic segments (2.3  1.6 vs. 1.4  1.6, p  0.0025) was signiﬁcantly higher,
whereas the number of delayed enhancement segments did not differ (1.4  1.6 vs. 1.6  2.3, p  0.4).
Target vessel revascularization was required in 38% of patients with PD and 6% of patients without PD
(p  0.005). In addition, the percentage of freedom from AP and dyspnea at the follow-up after 18  8
months was signiﬁcantly lower among patients without perfusion deﬁcit (69.4% vs. 15.6%; p 0.0001). After
a follow-up period of 30  8 months, the rate of AP (11.1% vs. 8.3%, p  0.33) as well as the percentage of
patients free of symptoms was similar in both groups (77.8% vs. 88.9%, p  0.82).
CONC L U S I O N S Adenosine stress CMR may help to identify patients at risk who beneﬁt from
intensiﬁed medical treatment and close follow-up. (J Am Coll Cardiol Img 2009;2:424–33) © 2009 by
the American College of Cardiology Foundation
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425oronary angiography (CA) is the gold stan-
dard for the evaluation of coronary artery
stenoses. In patients with mild or severe
stenoses, the angiographic assessment is
sually straightforward. However, the correct inter-
retation of coronary lesions of intermediate severity
diameter of stenosis 50% to 75%) is challenging
1–3). CA only provides a morphological description
f coronary lesions. The patient’s prognosis, however,
s closely related to the functional significance of
ngiographically detected coronary lesions (4–7).
herefore, a functional assessment is desirable in
atients with coronary artery stenoses of intermedi-
te severity.
See page 434
Former stress single-photon emission computed
omography (SPECT) studies (8–11) proved that
nducible ischemia is a predictor of future cardiac
vents in patients with known or suspected coronary
rtery disease. However, it requires the exposure to
onizing radiation. Adenosine stress cardiac mag-
etic resonance (CMR) is a noninvasive imaging
odality that has been shown to accurately predict
oronary artery disease (CAD) in patients sched-
led for CA (12–14). A study (15) comparing
denosine stress CMR with fractional flow reserve
FFR) as the gold standard could prove that stress
est perfusion CMR is able to distinguish hemody-
amically relevant from nonrelevant coronary le-
ions with high sensitivity and specificity. There-
ore, adenosine stress CMR might facilitate patient
election, especially among patients with diabetes or
ith diffuse CAD and several intermediate coro-
ary artery stenoses, in whom symptoms cannot
eliably be attributed.
As the ischemic burden correlates with the car-
iac event rate (16), the aim of our study was to
etermine the role of adenosine stress CMR for the
dentification of patients at risk with coronary artery
tenoses of intermediate angiographic severity.
herefore, we investigated whether perfusion CMR
s a suitable technique to distinguish between pa-
ients for whom an intensive medical treatment is
he optimal strategy and patients who may profit
rom close follow-up and—potentially—from early
evascularization.
E T H O D S
tudy design and patients. Patients referred to our
ospital for elective surgery were consecutively Ccreened between January 2006 and May 2007.
atients were eligible if they had 1 or more target
esions of 50% to 75% diameter stenoses. Pa-
ients with multivessel disease were also included if
o other main epicardial vessel showed a lesion
uitable for percutaneous coronary intervention
PCI) beyond the target vessel.
All patients who met the study criteria agreed
o participate and had no contraindication to
MR (e.g., pacemaker, claustrophobia) or to
denosine (e.g., more than second-degree atrio-
entricular block, severe obstructive pulmonary
isease) were recruited. An adenosine stress CMR
as performed in 85 patients. In 4 patients, adeno-
ine stress CMR was discontinued because of claus-
rophobia (n  2), angina (n  1), and amblyacou-
ia (n  1).
All patients gave written consent for
articipation, and the study was approved
y the local ethics committee. Adenosine
tress CMR was performed 7.4 8.0 days
fter CA to determine the functional sig-
ificance of the intermediate stenoses. To
nsure minimal basal blood flow and a
aximal vasodilatory response to adeno-
ine, patients were instructed to refrain
rom smoking and ingesting tea, coffee,
nd chocolate 24 h before the adenosine
tress CMR. Patients were monitored for
otential complications throughout the
maging procedure. Heart rate and blood
ressure were continuously monitored
uring rest-stress examinations. All adeno-
ine stress CMR and angiograms were
eassessed by 2 experienced readers for
linical and angiographical stability. All
atients with intermediate stenoses that
eemed to be angiographically stable were
ischarged with optimized medical therapy that
as intensified during the following weeks to max-
mally tolerated doses. The intensity of medical
herapy was evaluated on the ranking of medications
y drug class modified according to Mahmarian
t al. (5).
At 18  8 months and 30  8 months, clinical
nformation was obtained from patient telephone
nterviews, contact with the patients’ physicians,
nd hospital records. A standardized questionnaire
as used during the telephone interviews to assess
atient symptoms, major adverse events, secondary
nd points, and medications. Typical angina pecto-
is (AP) was classified according to the Canadian
A B B
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426V (17) by experienced cardiologists who were
linded to the CMR results.
Primary end points were defined as all causes of
eaths, stroke, and acute coronary syndrome
ACS). According to the American College of
ardiology/American Heart Association (ACC/
HA) guidelines (18,19), ACS comprises unstable
ngina, non–ST-segment elevation myocardial in-
arction, and ST-segment elevation myocardial in-
arction. Non–ST-segment elevation myocardial
nfarction was defined as typical chest pain with no
T-segment elevation and an increase in creatine
inase and creatine kinase-myocardial band to 2
imes the upper limit of normal, with a creatine
inase-myocardial band fraction of 4% or more of
otal creatine kinase or a positive troponin I or T.
n ST-segment elevation myocardial infarction
as diagnosed if ST-segment elevation of 1 mm
n 2 or more leads or ST-segment depression of at
east 2 mm was present. Patients with new angina
r worsening angina without significant ST-
egment elevation or increased troponin were clas-
ified as unstable angina. The secondary end points
ncluded TVR and AP or dyspnea at follow-up.
A and image interpretation. CA was performed
ith a conventional angiography unit (Integris H,
hilips Medical Systems, Hamburg, Germany).
oronary artery stenoses were imaged in the center
f the field from multiple projections, and overlap
f side branches and foreshortening of relevant
oronary arteries were avoided as much as possible.
uantitative coronary angiography. QCA was per-
ormed by 2 experienced interventional cardiolo-
ists unaware of the CMR results using the QCA
oftware (ACA, Philips Medical Systems). The
iameter of the guiding catheter, which ranged
rom 5- to 7-F, was used as the calibration
eference.
Measurements were made in the frame that
learly demonstrated the stenotic lesion and in-
luded the reference sites. From the QCA images,
he angiographic percent area stenosis was calcu-
ated by selecting the angiographically normal prox-
mal and distal segments as the reference sites.
nder these conditions, the minimal diameter of
he stenosis was also determined. The maximal and
inimal distances from the center of the stenotic
esion to the outline of the vessel wall were mea-
ured. Finally, the angiographic length of the ste-
osis was determined by measuring the distance
etween the proximal and distal shoulders of the
tenosis. A reduction in the luminal diameter of fl0% to 75% was considered as stenosis of interme-
iate severity.
MR imaging protocol. The CMR imaging was per-
ormed by using 1.5-T system (Magnetom Sonata,
iemens Medical Systems, Erlangen, Germany)
quipped with high-performance gradients (maxi-
um amplitude 40 mT/m, slew rate 200 mT/m)
20). An 18-gauge catheter was inserted into an
ntecubital vein for injection of the contrast agent
nd into an antecubital vein of the contralateral arm
or the adenosine infusion. CMR-compatible elec-
rocardiography leads were placed on the patient’s
hest. Imaging was performed by using a phased-
rray surface coil as a receiver.
denosine perfusion CMR. Left ventricular short-
xis orientation was used for perfusion CMR. For
yocardial perfusion measurements, 3 representa-
ive short-axis sections were obtained, 1 each in the
asal, midventricular, and apical regions of the left
entricle according to the segment model of the
HA (21). Pharmacological stress was applied
sing adenosine, which was administered intrave-
ously at 140 g/kg body weight over 4 to 5 min
nder electrocardiographic and blood pressure
onitoring. Acquisition of perfusion CMR images
as started a few seconds after the injection of 0.1
mol gadopentetate dimeglumine per kilogram of
ody weight (Magnevist, Schering, Berlin, Ger-
any); perfusion images were obtained by using a
-dimensional saturation-recovery turbo-flash se-
uence (field of view 300 to 340 mm, time to
epeat/time to echocardiogram 2.4 ms/1.08 ms, flip
ngle 15°, bandwidth 840 Hz/pixel, voxel size 2.1
.6  8 mm) in parallel acquisition mode with an
cceleration factor of 2. Parallel imaging to shorten
he acquisition time was used. The bolus injection
f gadopentetate dimeglumine (at a flow rate of 4
l/s) was followed with a 25-ml flush of 0.9% NaCl
at a flow rate of 4 ml/s).
A delay of 10 min after the stress examination
llowed residual gadopentetate dimeglumine to be
ashed out of the myocardium. A second bolus of
.1 mmol gadopentetate dimeglumine was injected,
nd rest perfusion images were obtained with the
ame orientation and position before and after the
dministration of adenosine.
ate enhancement. Ten minutes after resting per-
usion, delayed enhancement images were ac-
uired in continuous short-axis and 4- and
-chamber long-axis views using an inversion-
ecovery gradient-recalled echocardiogram MR se-
uence. Parameters for inversion-recovery turbo-
ash 2-dimensional sequences were as follows: field
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427f view 300 to 340 mm, time to repeat/time to
chocardiogram 9.56 ms/4.38 ms, TI 200 to 360
s, flip angle 25°, matrix 166  256, and section
hickness 6 mm. The inversion time was chosen to
inimize the signal from normal myocardium.
mage analysis. Myocardial segments were assigned
o the 3 coronary arterial territories according to the
7-segment model of the AHA standardized myo-
ardial segmentation (21). An abnormal CMR
tudy was defined by the presence of a perfusion
efect during adenosine infusion. Perfusion scans
ere interpreted qualitatively by consensus of 2
xperienced readers blinded to angiography. A per-
usion deficit was defined as abnormal if it was
arker than the surrounding myocardium and if it
Figure 1. Examples of 2 Representative CMR Studies
The coronary angiograms (upper panel) of 2 representative patient
onary artery (arrows). In both patients, a cardiac magnetic resonanc
as delayed enhancement was performed to determine the hemody
perfusion deﬁcit (PD) on stress perfusion and a normal delayed enh
enhancement but exhibits a perfusion deﬁcit on the inferior wall du
ischemia. The example illustrates that CMR is able to provide inform
intermediate coronary lesions.ersisted more than 5 images beyond initial peak
nhancement of the segment that appeared most
ormal. Delayed enhancement images were dis-
layed with a gray scale to optimally show normal
yocardium as dark and regions of delayed en-
ancement or fat as bright tissue. Myocardial isch-
mia was defined as a segment with a perfusion
eficit at stress and no hyperenhancement at de-
ayed enhancement. A myocardial scar was defined
s a segment with a hyperenhancement at delayed
nhancement.
tatistical analysis. Mean values between 2 catego-
ies were compared with a 2-tailed unpaired t test.
he chi-square test was used for dichotomous
nalysis of categorical data. Chi-square statistics
th stenoses of intermediate angiographic severity of the right cor-
MR) study including adenosine stress and rest perfusion as well
ic relevance of the stenosis. One patient (left panels) shows no
ement. The other patient (right panels) also has a normal delayed
adenosine stress (arrow), indicating stress-induced myocardial
n about the functional signiﬁcance of angiographically detecteds wi
e (C
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428ere used to compare baseline characteristics be-
ween patients with intermediate coronary steno-
es and perfusion deficits on CMR and normal
MR images. The log-rank test (Mantel-Cox) was
pplied for the evaluation of secondary end points.
ultivariate Cox regression analysis was used to
ompare the association of TVR with perfusion
eficits seen on CMR, cardiovascular risk factors,
ex, and age. Kaplan-Meier survival was used to
stimate event-free survival and survival of death
rom cardiovascular causes. All probability values
eported are 2-sided, and a p value 0.05 was
onsidered to indicate statistical significance. Sta-
istical analysis was done with SPSS software,
Table 1. Baseline Characteristics of Patients With and Without P
Yes
(n 
Age, yrs, mean  SD 65.5
Male, n (%) 34/45
Cardiovascular risk factors, n (%)
Hypertension 34/45
Diabetes mellitus 13/45
Family history of CAD 16/45
Hyperlipidemia 27/45
Smoking 17/45
Ejection fraction, mean  SD 58
Medical history, n (%)
Coronary artery disease
1-vessel 9/45
2-vessel 18/45
3-vessel 18/45
Lesions of intermediate severity 52
RCA 14/52
LAD 19/52
LCX 19/52
Prior myocardial infarction 12/45
Prior coronary interventions 15/45
PTCA/stent 11/15
CABG 4/15
CABG  coronary artery bypass graft surgery; CAD  coronary artery diseas
percutaneous transluminal coronary angioplasty; RCA  right coronary artery.
Table 2. Stenosis Characteristics
(n
Diameter stenosis (%) of target lesion, mean  SD 55
Length of stenotic segment (mm), mean  SD 4.
Minimal lumen diameter (mm), mean  SD 0.Reference diameter (mm), mean  SD 1.7ersion 15 for Windows (SPSS, Inc., Chicago,
llinois). Event classification was performed by an
nvestigator blinded to the result of the CMR and
he angiogram.
E S U L T S
aseline characteristics. Eighty-one consecutive pa-
ients with intermediate stenoses assessed by CA
nd stable AP were enrolled. According to the
denosine stress CMR result, patients were as-
igned either to the group with perfusion deficit or
o the group without perfusion deficit, as illustrated
n Figure 1. The baseline characteristics of the 2
usion Deﬁcit
Perfusion Deﬁcit
p Value
No
(n  36)
63.1 10 0.38
(75.6) 33/36 (91.7) 0.12
(75.6) 24/36 (66.7) 0.25
(28.9) 10/36 (27.8) 0.51
(35.6) 12/36 (33.3) 0.61
(60.0) 20/36 (55.6) 0.51
(37.8) 15/36 (41.7) 0.99
54 11 0.12
(20.0) 8/36 (22.2) 0.78
(40.0) 15/36 (41.7) 0.99
(40.0) 13/36 (36.1) 0.40
51 0.80
(26.9) 17/51 (33.3)
(36.5) 19/51 (37.3)
(36.5) 15/51 (29.4)
(26.7) 12/36 (33.3) 0.80
(35.6) 13/36 (36.1) 0.98
(73.3) 11/13 (84.6)
(26.7) 2/13 (15.4)
D  left anterior descending artery; LCX  left circumﬂex artery; PTCA 
Perfusion Deﬁcit Level of Signiﬁcance
s
45)
No
(n  36) p Value
8.4 54.7 7.2 0.98
1.8 4.65 1.8 0.90
0.3 0.77 0.2 0.18erf
45)
9.2
10
e; LAYe

.8
68
800.5 1.69 0.4 0.83
s
t
t
b
d
b
w
m
E
i
t
d
g
o
1
c
p
t
c
s
s
i
A
t
b
b
m
s
s
d
w
(
f
i
i
e
h
D
A
8
C
i
s
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 2 , N O . 4 , 2 0 0 9
A P R I L 2 0 0 9 : 4 2 4 – 3 3
Doesch et al.
Risk Stratification by Adenosine Stress CMR
429tudy groups were comparable (Table 1). Moreover,
here was no difference in the severity or length of
he stenotic lesion assessed by quantitative CA
etween the 2 groups (Table 2). The medication
uring follow-up was not significantly different in
oth groups, either (Table 3). Telephone follow-up
as obtained for all patients (100%) after 18  8
onths and 30  8 months.
xtent of PD. The extent, type, and location of the
schemic PD, the delayed enhancement (DE), and
he total PD is displayed in Table 4. There is no
ifference in the extent and location of DE in both
roups (1.9 2.4 vs. 1.2 2.1, p 0.7). However,
nly 45 patients display an ischemic PD of 2.4 
.4 segments, and therefore present with a signifi-
antly extended total PD (4.3  2.6 vs. 1.2  2.1,
 0.001). The ischemic PD is equally distributed
o all 3 coronary artery territories, and there is no
orrelation between the number of ischemic PD
egments assessed by CMR and the degree of
tenosis analyzed by QCA.
The presence and extent of ischemia did not
nfluence medial therapy or the decision for TVR.
ll patients were assigned to an optimized medical
herapy regardless of their PD. Analyzing the num-
er of ischemic segments and segments with DE, it
ecomes evident that the number of ischemic seg-
ents (2.3  1.6 vs. 1.4  1.6, p  0.0025) was
ignificantly increased in the 9 patients who had a
Table 3. Medical Therapy at Follow-Up
Yes
(n  45)
Follow-up 18  8 months, n (%)
Beta-blocker 45/45 (
ACEI/ARB 39/45 (
Statins 40/45 (
Diuretics 17/45 (
Calcium-channel blocker 6/45 (
Nitrates 6/45 (
Aspirin 45/45 (
Follow-up 30  8 months, n (%)
Beta-blocker 44/45 (
ACEI/ARB 39/45 (
Statins 38/45 (
Diuretics 13/45 (
Calcium-channel blocker 5/45 (
Nitrates 4/45 (
Aspirin 45/45 (
ACE  angiotensin-converting enzyme inhibitor; ARB  angiotensin receptor bubsequent major adverse cardiac event (MACE)uring the follow-up period of 30  8 months,
hereas the number of DE segments did not differ
1.4  1.6 vs. 1.6  2.3, p  0.4). At the first
ollow-up after 18  8 months, the number of
schemic PD segments in the 28 patients complain-
ng of persistent stable angina was significantly
levated (3.0  1.9 vs. 2.0  2.1, p  0.04);
owever, there was no difference in the number of
E segments (2.1  2.8 vs. 1.3  2.0, p  0.18).
fter the follow-up period of 30  8 months, only
patients still complained about stable angina.
omparing the number of ischemic segments at
nitial presentation of these patients with the 73
ymptom-free patients, the number of ischemic
Perfusion Deﬁcit
p Value
No
(n  36)
) 34/36 (94%) 0.37
%) 34/36 (94.4%) 0.45
%) 33/36 (91.7%) 0.99
%) 15/36 (41.7%) 0.68
%) 7/36 (19.4%) 0.63
%) 5/36 (13.9%) 0.99
) 36/36 (100%) 0.99
%) 33/36 (91.7%) 0.45
%) 33/36 (91.7%) 0.72
%) 30/36 (83.3%) 0.99
%) 13/36 (36.1%) 0.50
%) 7/36 (19.4%) 0.46
) 4/36 (11.1%) 0.99
) 36/36 (100%) 0.99
er.
Table 4. Extent of PD
PD
Yes
(n  45)
No
(n  36)
Number of ischemic segments 2.41.4 0
RCA 0.9 1.1 0
LAD 0.7 1.1 0
LCX 0.8 1.1 0
Delayed enhancement 1.9 2.4 1.2 2.1
RCA 0.5 1.1 0.4 1.0
LAD 0.5 1.0 0.41.0
LCX 0.8 1.6 0.3 0.9
Total PD (ischemic PD  DE) 4.3 2.6 1.2 2.1100%
86.7
88.9
37.8
13.3
13.3
100%
97.8
86.7
84.4
28.9
11.1
8.9%
100%
lockp
Value
0.001
0.7
0.001PD  perfusion deﬁcit; other abbreviations as in Table 1.
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430Ds did not vary (2.3  2.3 vs. 2.3  2.2, p 
.97). Analyzing the patients who underwent TVR
uring the follow-up period of 30  8 months,
here was also no significant difference regarding
he number of ischemic segments in patients who
nderwent TVR during follow-up and patients who
id not need TVR during follow-up (1.9  1.6 vs.
.4  1.6, p  0.29).
ncidence of major adverse events. Table 5 shows the
ncidence of major adverse events (primary end
oint). During the follow-up period of 30  8
onths, no patient died or had a stroke. In the
roup of patients without a PD, no patient had any
ajor adverse event. In contrast, in the group of
atients with a PD, 9 of 45 (20%) had an ACS
p  0.014 for comparison with the group without
00
90
80
70
0 5 10 15 20 25 30 35 40 45
Follow-up (months)
Perfusion deficit
No perfusion deficit
p=0.014
Primary End Points
d points: Kaplan-Meier curves demonstrate the event-free survival
ents without perfusion deﬁcit (orange line) and of patients with
eﬁcit (PD) (brown line) on adenosine stress test during the fol-
riod of 30  8 months. Differences between curves are statisti-
cant (p  0.014 by log-rank test). As all major adverse events
ke, acute coronary syndrome) occur in the patient group with a
nosine stress test, the occurrence of a PD during adenosine stress
gnetic resonance seems to indicate an enhanced risk of develop-
Table 5. Primary End Points After 30  8 Months
Yes
(n  45)
Death, n (%) 0/45
Stroke, n (%) 0/45
Acute coronary syndrome, n (%) 9/45
STEMI 0/45
NSTEMI 8/45
Unstable angina 1/45
NS  not signiﬁcant; NSTEMI  non–ST-segment elevation myocardial infarctiol
e cardiac events.PD). Figure 2 shows the cumulative event-free
urvival from major adverse events depending on
he result of the initial CMR.
ncidence of secondary end points. Secondary end
oints in both groups are described in Table 6 after
8  8 months and after 30  8 months. It should
e noted that in patients with PD, the rate of TVR
fter 18 8 months (28.9% vs. 5.5%, p 0.05) and
fter 30 8 months (37.8% vs. 5.5%, p 0.05) was
ignificantly higher. The result from multivariate
ox regression analysis for TVR at 30  8 months,
ncluding sex, age, and cardiovascular risk factors,
nd ischemic PD identified the existence of isch-
mic PD as the only independent factor influencing
he occurrence of TVR during follow-up (0.14,
5% confidence interval: 0.031 to 0.627, p  0.01).
t a follow-up period of 18  8 months, AP was
ore frequent among patients with PD (53.3% vs.
1.1%, p  0.01) (Fig. 3). At this time, patients
ith PD also seemed to suffer more frequently from
yspnea; however, this was not significantly differ-
nt (p  0.08). Despite optimal medical therapy in
oth groups, the percentage of patients free from
P or dyspnea after 18  8 months was signifi-
antly higher in the patient cohort without PD
69.4% vs. 15.6%, p  0.0001). However, after a
ollow-up period of 30  8 months, the rate of AP
n patients who presented initially with PD and
atients without PD was not different any more
11.1% vs. 8.3%, p  0.33). This result also ap-
lied to the percentage of patients free of symp-
oms that aligned in both groups (77.8% vs. 88.9%,
 0.82).
I S C U S S I O N
he primary objective of this study was to analyze
he prognostic value of PD detected on adenosine
tress CMR in patients with intermediate coronary
Perfusion Deﬁcit
p Value
No
(n  36)
) 0/36 (0%) NS
) 0/36 (0%) NS
) 0/36 (0%) 0.014
) 0/0 (0%)
%) 0/0 (0%)
) 0/0 (0%)
TEMI  ST-segment elevation myocardial infarction.1
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431ediate coronary artery stenoses and a normal
MR represent a patient cohort with an excellent
rognosis who benefit from intensive medical treat-
ent and do not require coronary revascularization.
n contrast, PD on adenosine stress CMR in
atients with intermediate stenoses seem to depict a
atient cohort that at least requires a close follow-
p. Patients with a PD detected on adenosine stress
MR seem to be at enhanced risk for the develop-
ent of adverse cardiac events and to have a more
ronounced need for TVR.
These findings are in line with previous studies
emonstrating that stress-induced myocardial isch-
mia is a valuable prognostic marker for patients
ith stable AP as proven by various studies using
he SPECT technique (4,22–24) or pharmacologi-
al stress echocardiography (25–28). In patients
ith intermediate stenoses, the DEFER (Deferral
ersus Performance of PTCA in Patients Without
ocumented Ischemia) study (6) showed that the
-year outcome of patients after deferral of PCI was
xcellent and could not be improved by stenting.
owever, the decision to defer PCI in this study
as based on invasive functional flow reserve mea-
Table 6. Incidence of Secondary End Points
Yes
(n  45)
Follow-up 18  8 months, n (%)
Target vessel revascularization 13/45 (
Stenting 7/13 (
CABG 6/13 (
Angina pectoris 24/45 (
CCS I 0/24 (
CCS II 7/24 (
CCS III 10/24 (
CCS IV 7/24 (
Dyspnea 8/45 (
Freedom from symptoms 7/45 (
Follow-up 30  8 months, n (%)
Target vessel revascularization 17/45 (
Stenting 10/17 (
CABG 7/17 (
Angina pectoris 5/45 (
CCS I 0/5 (
CCS II 2/5 (
CCS III 3/5 (
CCS IV 0/5 (
Dyspnea 7/45 (
Freedom from symptoms 35/45 (
CABG  coronary artery bypass graft; CCS  Canadian Cardiovascular Societyurement, and the majority of patients in the iEFER study had a single stenosis. Our results
uggest that this also seems to be valid for adenosine
tress CMR in patients with intermediate stenoses
nd even in patients with multivessel disease, since
5% of our patients had 2- or 3-vessel disease.
All MACE occurred in the patient subgroup
ith a PD on CMR, and the rate of TVR after 30
8 months accounted for 37.8% versus 5.5% in
he group with a normal CMR (p  0.005).
onversely, 62% of patients with a PD on the
nitial CMR did well with intensified medical
reatment alone. These results indicate that
mong patients with functionally relevant inter-
ediate coronary stenoses, optimized medical
herapy is a successful strategy for the majority of
atients. The significant reduction in stable an-
ina to only 8 of 81 (9.9%) and the increased
umber of patients free from symptoms, 64 of 81
79%), after the follow-up period of 30  8
onths suggests that the optimal medical treat-
ent and PCI, if indicated, was effective in
uppressing ischemia in our patient cohort. Our
ata indicate that adenosine stress CMR is able
o determine the ischemic significance of an
Perfusion Deﬁcit
p Value
No
(n  36)
%) 2/36 (5.5%) 0.05
%) 2/2 (100%)
%) 0/2 (0%)
%) 4/36 (11.1%) 0.01
0/4 (0%)
%) 2/4 (50.0%)
%) 2/4 (50.0%)
%) 0/4 (0%)
%) 2/36 (5.6%) 0.08
%) 25/36 (69.4%) 0.0001
%) 2/36 (5.5%) 0.005
%) 2/2 (100%)
%) 0/2 (0%)
%) 3/36 (8.3%) 0.33
0/3 (0%)
%) 2/3 (66.7%)
%) 1/3 (33.3%)
%) 0/3 (0%)
%) 1/36 (2.8%) 0.048
%) 32/36 (88.9%) 0.82
iﬁcation.28.9
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diologists at predicting the hemody- 4. Beller GA, Zaret B
symptoms was not signiﬁcantly different for both groups.
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432valuation. It helps to identify patients who are at
nhanced risk and, therefore, may profit from
lose follow-up.
tudy limitations. The current number of 81 pa-
ients did not allow us to additionally randomize
atients with a PD for conservative versus interven-
ional treatment. Therefore, we can only demon-
trate that patients with a PD are at higher risk for
dverse events. Thus, this study does not allow the
rawing of conclusions that interventional treat-
ent is superior for patients with PD. Future
rospective randomized trials will have to clarify
his aspect.
O N C L U S I O N S
ur study suggests that patients with coronary
rtery stenoses of angiographic intermediate sever-
ty causing a PD in the initial CMR are at higher
isk for MACE within the following year and a
alf. Therefore, these patients should receive inten-
ified medical treatment, and close follow-up is
ecessary. Whether these patients would further
enefit from coronary revascularization has to be
larified in the future. Nevertheless, deferring PCI
n patients with intermediate coronary artery steno-
es and no PD on CMR seems to be safe.
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